Transitioning from intramuscular (IM) to oral aripiprazole in patients with schizophrenia

被引：0
|
作者：
Daniel, D. [1 ]
Crandall, D. [1 ]
Manos, G. [1 ]
McQuade, R. [1 ]
机构：
[1] Bioniche Dev Inc, United BioSource Inc, Mclean, VA USA
来源：
SCHIZOPHRENIA BULLETIN | 2007年 / 33卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：426 / 427
页数：2
相关论文
共 50 条
  • [11] Effects of aripiprazole once-monthly in patients with schizophrenia switched from oral antipsychotics to aripiprazole once-monthly
    Kane, J. M.
    Zhao, C.
    Johnson, B.
    Baker, R. A.
    Eramo, A.
    McQuade, R.
    Duca, A.
    Sanchez, R.
    Peters-Strickland, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S543 - S544
  • [12] Cardiac conduction in females and males under intramuscular (IM) and oral olanzapine from schizophrenia clinical trials ECGs
    Czekalla, J
    Beasley, C
    David, S
    Berg, PH
    Stauffer, V
    Boylan, C
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S291 - S292
  • [13] Intramuscular olanzapine versus intramuscular aripiprazole for the treatment of agitation in patients with schizophrenia: A pragmatic double-blind randomized trial
    Kittipeerachon, Mantana
    Chaichan, Warawat
    SCHIZOPHRENIA RESEARCH, 2016, 176 (2-3) : 231 - 238
  • [14] Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study
    Andrezina, R.
    Marcus, R. N.
    Oren, D. A.
    Manos, G.
    Stock, E.
    Carson, W. H.
    McQuade, R. D.
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (11) : 2209 - 2219
  • [15] Efficacy of aripiprazole-IM-depot in the treatment of schizophrenia
    Kane, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S444 - S444
  • [16] Hospitalization rates in patients switched from oral antipsychotics to aripiprazole once-monthly for schizophrenia
    Kane, J.
    Zhao, J.
    Baker, R. A.
    Eramo, A.
    McQuade, R. D.
    Sanchez, R.
    Peters-Strickland, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S480 - S480
  • [17] Effects of aripiprazole once-monthly on symptoms of schizophrenia in patients switched from oral antipsychotics
    Peters-Strickland, Timothy
    Zhao, Cathy
    Perry, Pamela P.
    Eramo, Anna
    Salzman, Phyllis M.
    McQuade, Robert D.
    Johnson, Brian R.
    Sanchez, Raymond
    CNS SPECTRUMS, 2016, 21 (06) : 460 - 465
  • [18] Intramuscular aripiprazole controls agitation in patients with schizophrenia or bipolar I disorder without excessive sedation
    Currier, G.
    Crandall, D.
    Archibald, D.
    Nyilas, M.
    Pikalov, A.
    Oren, D.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S253 - S253
  • [19] Efficacy and safety of intramuscular aripiprazole, haloperidol or placebo in acutely agitated patients with schizophrenia or schizoaffective disorder
    Oren, D
    Marcus, R
    Kostic, D
    McQuade, R
    Iwamoto, T
    Archibald, D
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 499 - 499
  • [20] Switching to aripiprazole from atypical antipsychotics in patients with schizophrenia
    Kim, S. W.
    Lee, J. H.
    Lee, Y. H.
    Chung, K. H.
    Ryu, J. H.
    Yoon, J. S.
    Kim, J. M.
    Yoo, J. A.
    Youn, T.
    Bae, K. Y.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S488 - S489
12345